Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ellen L. Smith, PhD, ARNP, AOCN
University of Michigan
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
475 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente - Deer Valley
Antioch, California, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California, United States
- Cancer Care Center at John Muir Health - Concord Campus
Concord, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Valley Medical Oncology
Fremont, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Camino Medical Group - Treatment Center
Mountain View, California, United States
- El Camino Hospital Cancer Center
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Breast Surgeons, Incorporated
Oakland, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Kaiser Permanente - Division of Research - Oakland
Oakland, California, United States
- Kaiser Permanente Medical Center - Oakland
Oakland, California, United States
- Larry G Strieff Md Medical Corporation
Oakland, California, United States
- Tom K Lee, Incorporated
Oakland, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- Facility name not stated
Pismo Beach, California, United States
- Kaiser Permanente Medical Center - Rancho Cordova
Rancho Cardova, California, United States
- Kaiser Permanente Medical Center - Redwood City
Redwood City, California, United States
- Kaiser Permanente Medical Center - Richmond
Richmond, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Kaiser Permanente Medical Center - Roseville
Roseville, California, United States
- Sutter Cancer Center at Roseville Medical Center
Roseville, California, United States
- Kaiser Permanente Medical Center - Sacramento
Sacramento, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- South Sacramento Kaiser-Permanente Medical Center
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office
San Diego, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Kaiser Permanente Medical Center - San Francisco Geary Campus
San Francisco, California, United States
- Kaiser Permanente Medical Center - Santa Teresa
San Jose, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2008
- Primary completion
- 31 Jan 2012
- Completion
- 31 Mar 2013
- Last update posted
- 26 Apr 2017
- Registered enrollment
- 231
- Registry id
- NCT00489411
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.